Nateglinide
Drug Category | Drug | IHD Dosing | Administration Timing Around HD Session |
---|---|---|---|
Diabetes Medications | Nateglinide | 60-180mg PO Q8H AC; start with low dose and titrate | Administer Anytime During HD |
Molecular Weight (Da) | Excreted Unchanged (%) | Normal Half-Life (Hours) | ESRD Half-Life (Hours) | Plasma Protein Binding (%) | Volume of Distribution (L/kg) | Dialytic Plasma Clearance (ml/min) | % Dialyzed |
---|---|---|---|---|---|---|---|
317 | 16 | 1.5 | N/A | 98 | 0.14 (based on 70 kg) | N/A | N/A |
References:
- DrugBank [Online]. 2012 Apr 12 [cited 2012 May 6]; Available from: URL: http://www.drugbank.ca/drugs/DB00731